As of 2026-03-18, the Fair Value of Medexus Pharmaceuticals Inc (MDP.TO) is -0.21 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.13 CAD, the upside of Medexus Pharmaceuticals Inc is -106.73%.
With the market price of 3.13 CAD and our fair value calculation, Medexus Pharmaceuticals Inc (MDP.TO) is not a good investment. Investing in MDP.TO stocks now will result in a potential loss of 106.73%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -28.26 | -2.88 | 1.22 | -0.21 | 2.25 | -5.58 |
| YoY growth | -352.88% | 89.81% | 142.41% | -117.53% | 1,150.00% | 182.36% |
| Market Cap (mil) | 101.10 |
| P/E | |
| Forward P/E | 38.14x |
| EPS | -0.01 |
| Avg earnings growth rate | 182.36% |
| TTM earnings | -0.27 |